ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) /
The revenue of ADAPTIVE BIOTECHNOLOGIES CORPORATION over the past 9 years
Chart ADAPTIVE BIOTECHNOLOGIES CORPORATION: revenue, fiscal 2017–2025 Open the chart →ADAPTIVE BIOTECHNOLOGIES CORPORATION reported revenue of $276.98M in fiscal 2025, the latest fiscal year on file. In fiscal 2017 it was $38.45M — up 620% over 8 years. Year over year, revenue rose 7 times and fell once. The largest one-year move was in fiscal 2021: up 57%, from $98.38M to $154.34M.
Year by year
| Fiscal year | Revenue |
|---|---|
| 2025ended Dec 31, 2025 | $276.98M |
| 2024ended Dec 31, 2024 | $178.96M |
| 2023ended Dec 31, 2023 | $170.28M |
| 2022ended Dec 31, 2022 | $185.31M |
| 2021ended Dec 31, 2021 | $154.34M |
| 2020ended Dec 31, 2020 | $98.38M |
| 2019ended Dec 31, 2019 | $85.07M |
| 2018ended Dec 31, 2018 | $55.66M |
| 2017ended Dec 31, 2017 | $38.45M |
Fiscal years as ADAPTIVE BIOTECHNOLOGIES CORPORATION reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on ADAPTIVE BIOTECHNOLOGIES CORPORATION
- The profitability of ADAPTIVE BIOTECHNOLOGIES CORPORATION
- The cash flow of ADAPTIVE BIOTECHNOLOGIES CORPORATION
- The debt of ADAPTIVE BIOTECHNOLOGIES CORPORATION
- All of ADAPTIVE BIOTECHNOLOGIES CORPORATION's financials, charted
Companies of a similar size
- MIRMirion Technologies, Inc.
- MDUMDU RESOURCES GROUP INC
- FHIFederated Hermes, Inc.
- BFHBREAD FINANCIAL HOLDINGS, INC.
- BDCBELDEN INC.
Not investment advice. This page shows what ADAPTIVE BIOTECHNOLOGIES CORPORATION filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.